WTR Healthcare Happenings
WTR Healthcare Happenings is a weekly conversation with healthcare executives, medical experts, and investors on recent clinical data or industry-driving events in healthcare.
WTR Healthcare Happenings
Oncolytics Biotech (ONCY): A Differentiated Approach to Treating Gastrointestinal Cancers
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
In this episode of WTR Healthcare Happenings, Oncolytics Biotech CEO Jared Kelly joins WTR's Tim Gerdeman and healthcare analyst Robert Sassoon to discuss the company's progress advancing pelareorep, its investigational oncolytic virus immunotherapy for difficult-to-treat gastrointestinal cancers. The conversation covers the significant unmet need in RAS-mutated colorectal, pancreatic, and anal cancers — tumor types that have largely not benefited from the immunotherapy advances seen in other cancers — and how pelareorep's systemically delivered mechanism selectively targets tumor cells while stimulating an anti-cancer immune response. Kelly also walks through recent clinical results, upcoming data readouts, regulatory progress, and Oncolytics' strategy to advance registration-directed colorectal cancer studies while pursuing partnership opportunities to support future development and commercialization.